Dr Richard Shaffer is a leading radiotherapy specialist and clinical oncologist based in London and Surrey. He has a specialist interest in treating benign (non-malignant) conditions with radiotherapy, including Dupuytren's disease, Ledderhose (plantar fibromatosis), Plantar Fasciitis, insertional Achilles Tendonitis and Keloid scarring. He uses the latest radiotherapy technology to do this.
Dr Richard Shaffer is president of the International Organisation for Radiotherapy for Benign Conditions. He is clinical lead for Benign Radiotherapy for GenesisCare UK. He is co-author of a 2015 Royal College of Radiologists document on the use of radiotherapy for benign conditions. Dr Richard Shaffer previously worked as the clinical lead for radiotherapy in Guildford and he chaired The Network Radiotherapy Group and the Radiotherapy Strategy Group.
Dr Richard Shaffer has also chaired the Radiotherapy Technology Development Group and led the Brain Tumour Working Group from 2010 to 2019. Dr Shaffer was the principal investigator on several treatment studies in prostate cancer, skin cancer and brain tumours. He supervised a clinical fellow in a programme of clinical and lab-based radiobiological research. Before working at Royal Surrey County Hospital, Dr Richard Shaffer undertook his oncology training in London and later completed a Clinical Fellowship in Radiation Oncology (treatment of cancer with radiotherapy) in Vancouver, Canada. Whilst in Canada he completed several research projects focused on technical radiotherapy, including the comparisons of VMAT with conventional IMRT therapy and RapidArc in several disease sites such as breast, prostate and high-grade glioma.